Skip to main content
. 2015 Jul 2;75(1):75–83. doi: 10.1136/annrheumdis-2015-207511

Figure 3.

Figure 3

(A) Clinical remission rates at weeks 24 and 52 by Simple Disease Activity Index (SDAI), Boolean and Disease Activity Score 28-joint assessment (DAS28) (erythrocyte sedimentation rate (ESR)) criteria analysed using full analysis set (FAS), last observation carried forward (LOCF) data set. Error bars indicate 95% confidence interval of each remission rate. P values are calculated by Fisher's exact test. (B-E) Time course of American College of Rheumatology (ACR) response rates of (B) ACR20, (C) ACR50, (D) ACR70 and (E) Health Assessment Questionnaire Disability Index (HAQ-DI) remission rates. *p<0.05 between the groups at each particular time point, calculated by Fisher's exact test. CZP, certolizumab pegol; MTX, methotrexate; PBO, placebo.